Month: March 2011

SEC ENFORCEMENT: MORE CASES, MORE INVESTEMENT FUND FRAUD ACTIONS

The retooled SEC enforcement program is filing more cases and securing judgments for more dollars than in prior years according to the statistics (here). A significant component of those statistics is investment fund fraud actions. Once considered difficult to discover

FDA CHEMIST CHARGED FOR SERIAL INSIDER TRADING

FDA chemist Cheng Yi Liang was named as a defendant along with his son Andrew Liang in a criminal insider trading complaint. U.S. v. Liang (D. Md. Filed March 29, 2011). The SEC filed a parallel action against the chemist.

Top